
72.88BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US75886F1075
CUSIP
75886F107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
16.98
PEG Ratio
1.22
Book Value
308.33
Dividend Share
3.58
Dividend Yield
0.51%
Earnings Share
40.96
Wall Street Target Price
819.25
EPS Estimate Current Year
45.81
EPS Estimate Next Year
47.36
EPS Estimate Current Quarter
8.9018
EPS Estimate Next Quarter
10.6426
Most Recent Quarter
-
Revenue TTM
14,919,600,128
Gross Profit TTM
6,547,500,032
EBITDA
4,382,799,872
Profit Margin
29.65%
Return On Assets TTM
6.13%
Return On Equity TTM
14.55%
Revenue Per Share TTM
143.561
Qtly Revenue Growth YOY
19.00%
Diluted Eps TTM
40.96
Qtly Earnings Growth YOY
-7.20%
Trailing PE
16.98
Forward PE
15
Price Sales TTM
4.8867
Price Book MRQ
2.3193
Enterprise Value Revenue
4
Enterprise Value EBITDA
11
22.75
2.52%865.00
0.00%88.94
0.00%124.85
-12.62%259.59
-12.18%853.82
-2.26%187.48
-2.14%57.97
-1.78%476.99
-0.98%204.11
-0.83%Curated watchlists where REGN is featured.